Accessibility Menu
Personalis Stock Quote

Personalis (NASDAQ: PSNL)

$10.48
(3.0%)
+0.31
Price as of December 4, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$10.48
Daily Change
(3.0%) +$0.31
Day's Range
$9.86 - $10.50
Previous Close
$10.48
Open
$10.09
Beta
2.29
Volume
950,522
Average Volume
1,319,788
Market Cap
930.7M
Market Cap / Employee
$10.48M
52wk Range
$2.83 - $11.40
Revenue
-
Gross Margin
0.27%
Dividend Yield
N/A
EPS
-$0.88
CAPs Rating
-
Industry
Life Sciences Tools and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Personalis Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
PSNL+162.66%-65.03%-18.94%-64%
S&P+12.66%+85.37%+13.13%+132%
Advertisement

Personalis Company Info

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

News & Analysis

Financial Health

General

Q3 2025YOY Change
Revenue$14.50M-43.6%
Gross Profit$1.91M-78.1%
Gross Margin13.20%-20.8%
Market Cap$578.17M102.0%
Market Cap / Employee$2.52M0.0%
Employees2291.8%
Net Income-$21.65M44.6%
EBITDA-$20.83M-79.2%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$49.97M-34.1%
Accounts Receivable$14.38M6.7%
Inventory3.7-41.1%

Liabilities

Q3 2025YOY Change
Long Term Debt$33.50M-7.0%
Short Term Debt$8.37M-8.4%

Ratios

Q3 2025YOY Change
Return On Assets-30.61%8.6%
Return On Invested Capital-36.01%-2.2%

Cash Flow

Q3 2025YOY Change
Free Cash Flow-$23.43M-263.5%
Operating Free Cash Flow-$21.80M-251.8%

Valuation

MetricQ4 2024Q1 2025Q2 2025Q3 2025YoY Change
Price to Book2.451.472.793.0332.91%
Price to Sales4.983.587.238.37122.92%
Price to Tangible Book Value2.451.472.793.0332.91%
Enterprise Value to EBITDA-18.02-11.02-23.39-22.5514.00%
Return on Equity-48.9%-51.3%-60.3%-43.7%-24.03%
Total Debt$44.35M$45.23M$43.26M$41.87M-7.27%

No results found

No podcast episodes available.

Advertisement

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.